Home
/
60 DEGREES PHARMACEUTICALS, INC.
/
Financials
/
Quarterly
60 DEGREES PHARMACEUTICALS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that 60 DEGREES PHARMACEUTICALS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$437.6K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$100.9K
Aug 13, 2025
Q1
2025
Mar 31, 2025
$163.6K
May 15, 2025
Q3
2025
Sep 30, 2024
$135.3K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$125.0K
Aug 13, 2025
Q1
2025
Mar 31, 2024
$105.7K
May 15, 2025
Q3
2024
Sep 30, 2023
$51.2K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$59.5K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$17.2K
May 15, 2024
Q3
2023
Sep 30, 2022
$168.2K
Nov 20, 2023
Q2
2023
Jun 30, 2022
$45.2K
Aug 25, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.32M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.73M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.88M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.16M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($4.17M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
$430.5K
May 15, 2025
Q3
2024
Sep 30, 2023
$4.18M
Nov 14, 2024
Q2
2024
Jun 30, 2023
($3.34M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.60M)
May 15, 2024
Q3
2023
Sep 30, 2022
($1.45M)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($2.15M)
Aug 25, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.33M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.60M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.91M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.12M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($4.19M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($1.34M)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.52M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($788.0K)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($950.7K)
May 15, 2024
Q3
2023
Sep 30, 2022
($215.1K)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($686.9K)
Aug 25, 2023